Current position:Home >Product >
(2-METHOXY-5-[2-(2,4,6-TRIMETHOXY-PHENYL)-ETHENESULFONYLMETHYL]-PHENYLAMINO)-ACETIC ACID, SODIUM SALT
(2-METHOXY-5-[2-(2,4,6-TRIMETHOXY-PHENYL)-ETHENESULFONYLMETHYL]-PHENYLAMINO)-ACETIC ACID, SODIUM SALT(592542-59-1)
- Name: (2-METHOXY-5-[2-(2,4,6-TRIMETHOXY-PHENYL)-ETHENESULFONYLMETHYL]-PHENYLAMINO)-ACETIC ACID, SODIUM SALT
- Synonyms:(2-METHOXY-5-[2-(2,4,6-TRIMETHOXY-PHENYL)-ETHENESULFONYLMETHYL]-PHENYLAMINO)-ACETIC ACID, SODIUM SALT;Glycine, N-[2-Methoxy-5-[[[(1E)-2-(2,4,6-triMethoxyphenyl)ethenyl]sulfonyl]Methyl]phenyl]-;(E)-2-((2-Methoxy-5-(((2,4,6-triMethoxystyryl)sulfonyl)Methyl)phenyl)aMino)acetic acid;3: PN: WO2006074149 PAGE: 45 claiMed sequence;Rigosertib
- Molecular Formula:C21H25NO8S
- Molecular Weight:451.497
- CAS Registry Number:592542-59-1
- EINECS:
- Melting Point:172-174 °C(Solv: acetone (67-64-1))
- Water Solubility:
Other Product
- 1005201-24-0/2-Methyl-5-[3-[4-(methylsulfinyl)phenyl]-5-benzofuranyl]-1,3,4-oxadiazole
- 876761-22-7/3(4H)-QuinazolinebutanaMide, 2-aMino-N,g-dicyclohexyl-N-Methyl-6-phenoxy-, (hydrobroMide) (1:1), (gS)- , (HBr salt)
- 877032-57-0/3(4H)-Quinazolinebutanamide, 2-amino-N,g-dicyclohexyl-N-methyl-6-phenoxy-, (gS)-
- 940948-68-5/GRL-7234
- 913071-81-5/GRL-8234
- 1144076-41-4/Urea, N-[4-(4-Methyl-1-piperazinyl)phenyl]-N'-[4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyriMidin-6-yl]phenyl]-, CF3COOH salt
- 1144072-40-1/Urea, N-[4-(4-methyl-1-piperazinyl)phenyl]-N'-[4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-
- 677298-35-0/Phenol, 3,3'-(2,4-diamino-6,7-pteridinediyl)bis-, H2SO4 slat
- 618385-01-6/Vorapaxar
- 705260-08-8/Vorapaxar Sulfate
- 592542-59-1/(2-METHOXY-5-[2-(2,4,6-TRIMETHOXY-PHENYL)-ETHENESULFONYLMETHYL]-PHENYLAMINO)-ACETIC ACID, SODIUM SALT
- 592542-60-4/Glycine, N-[2-methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-, sodium Slat
- 946420-45-7/4-Pyridinecarboxamide, N-[(1S,2R)-2-amino-3-fluoro-1-(phenylmethyl)propyl]-2-[[[(1S,2S)-2-methylcyclopropyl]methyl]amino]-6-[methyl[(1-methylethyl)sulfonyl]amino]-, CF3COOH salt
- 860311-93-9/4-Pyridinecarboxamide, N-[(1S,2R)-2-amino-3-fluoro-1-(phenylmethyl)propyl]-2-[[[(1S,2S)-2-methylcyclopropyl]methyl]amino]-6-[methyl[(1-methylethyl)sulfonyl]amino]-
- 452342-67-5/GW788388
- 452342-37-9/GW-6604
- 356068-94-5/Toceranib
- 651744-16-0/BMS645737
- 1000669-72-6/[4-[2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone
- 451492-95-8/MP-412
- 843653-25-8/2H-1-Benzopyran-5-carboxamide, 3-[cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino]-8-fluoro-3,4-dihydro-, (3R)-
- 843653-28-1/2H-1-Benzopyran-5-carboxamide, 3-[cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino]-8-fluoro-3,4-dihydro-, hydrochloride (1:1), (3R)-
- 885616-78-4/PI-540
- 677297-55-1/Phenol, 3,3'-(2,4-diamino-6,7-pteridinediyl)bis-, 2 HCL salt
- 1005202-76-5/1,3,4-Oxadiazole, 2-[3-[4-(ethylsulfinyl)phenyl]-5-benzofuranyl]-5-methyl-
- 1005203-17-7/s-1,3,4-Oxadiazole, 2-[3-[4-(ethylsulfinyl)phenyl]-5-benzofuranyl]-5-Methyl-
- 1005203-15-5/s-1,3,4-Oxadiazole, 2-Methyl-5-[3-[4-(Methylsulfinyl)phenyl]-5-benzofuranyl]-
- 607833-11-4/Benzeneacetic acid, 3-[(aminoiminomethyl)amino]-a-(mercaptomethyl)-, CF3COOH slat
- 607833-29-4/Benzeneacetic acid, 3-[(aminoiminomethyl)amino]-a-(mercaptomethyl)-,(-)
- 162760-96-5/CYCLOHEXANECARBOXAMIDE, N-[2-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]ETHYL]-N-2-PYRIDINYL-, HYDROCHLORIDE (1:3)